265 related articles for article (PubMed ID: 28882011)
1. Comments on practice guidelines for the diagnosis and management of aspergillosis made by the IDSA in 2016.
Alarcón-Manoja E; Cardozo-Espinola C; Puerta-Alcalde P; García-Vidal C
Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():26-29. PubMed ID: 28882011
[TBL] [Abstract][Full Text] [Related]
2. EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis.
Cornely OA; Koehler P; Arenz D; C Mellinghoff S
Mycoses; 2018 Nov; 61(11):833-836. PubMed ID: 29944740
[TBL] [Abstract][Full Text] [Related]
3. Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Patterson TF; Thompson GR; Denning DW; Fishman JA; Hadley S; Herbrecht R; Kontoyiannis DP; Marr KA; Morrison VA; Nguyen MH; Segal BH; Steinbach WJ; Stevens DA; Walsh TJ; Wingard JR; Young JA; Bennett JE
Clin Infect Dis; 2016 Aug; 63(4):433-42. PubMed ID: 27481947
[TBL] [Abstract][Full Text] [Related]
4. ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children.
Warris A; Lehrnbecher T; Roilides E; Castagnola E; Brüggemann RJM; Groll AH
Clin Microbiol Infect; 2019 Sep; 25(9):1096-1113. PubMed ID: 31158517
[TBL] [Abstract][Full Text] [Related]
5. Levels of evidence supporting clinical practice guidelines on invasive aspergillosis.
Tejada S; Campogiani L; Ferreira-Coimbra J; Blot S; Rello J
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):903-913. PubMed ID: 31901113
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of epidemiology, risk factors, diagnosis, antifungal resistance, and management of invasive aspergillosis in Africa.
Yerbanga IW; Nakanabo Diallo S; Rouamba T; Denis O; Rodriguez-Villalobos H; Montesinos I; Bamba S
J Mycol Med; 2023 Mar; 33(1):101328. PubMed ID: 36265260
[TBL] [Abstract][Full Text] [Related]
7. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Patterson TF; Thompson GR; Denning DW; Fishman JA; Hadley S; Herbrecht R; Kontoyiannis DP; Marr KA; Morrison VA; Nguyen MH; Segal BH; Steinbach WJ; Stevens DA; Walsh TJ; Wingard JR; Young JA; Bennett JE
Clin Infect Dis; 2016 Aug; 63(4):e1-e60. PubMed ID: 27365388
[TBL] [Abstract][Full Text] [Related]
8. Defining standards of CARE for invasive fungal diseases in the ICU.
Cuenca-Estrella M; Kett DH; Wauters J
J Antimicrob Chemother; 2019 Mar; 74(Suppl 2):ii9-ii15. PubMed ID: 31222308
[TBL] [Abstract][Full Text] [Related]
9. Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis.
Colombo AL; De Almeida JN; Lewis RE; Kontoyiannis DP
J Antimicrob Chemother; 2022 Oct; 77(11):2897-2900. PubMed ID: 36059133
[TBL] [Abstract][Full Text] [Related]
10. Invasive Fungal Infections in the Intensive Care Unit.
Ostrosky-Zeichner L; Al-Obaidi M
Infect Dis Clin North Am; 2017 Sep; 31(3):475-487. PubMed ID: 28687215
[TBL] [Abstract][Full Text] [Related]
11. A clinical perspective for the management of invasive fungal infections: focus on IDSA guidelines. Infectious Diseases Society of America.
Kontoyiannis DP
Pharmacotherapy; 2001 Aug; 21(8 Pt 2):175S-187S. PubMed ID: 11501990
[TBL] [Abstract][Full Text] [Related]
12. Training should be the first step toward an antifungal stewardship program.
Valerio M; Muñoz P; Rodríguez-González C; Sanjurjo M; Guinea J; Bouza E;
Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):221-7. PubMed ID: 25066382
[TBL] [Abstract][Full Text] [Related]
13. Early diagnosis and treatment of invasive aspergillosis as a main determinant of outcome - review of literature according to the presented case report.
Borys M; Piwowarczyk P; Sysiak J; Czuczwar M; Prystupa A
Ann Agric Environ Med; 2017 Mar; 24(1):100-103. PubMed ID: 28378982
[TBL] [Abstract][Full Text] [Related]
14. When to change treatment of acute invasive aspergillosis: an expert viewpoint.
Slavin MA; Chen YC; Cordonnier C; Cornely OA; Cuenca-Estrella M; Donnelly JP; Groll AH; Lortholary O; Marty FM; Nucci M; Rex JH; Rijnders BJA; Thompson GR; Verweij PE; White PL; Hargreaves R; Harvey E; Maertens JA
J Antimicrob Chemother; 2021 Dec; 77(1):16-23. PubMed ID: 34508633
[TBL] [Abstract][Full Text] [Related]
15. [Update on the management of fungal infections].
Wintenberger C
Med Mal Infect; 2011 Nov; 41(11):633-7. PubMed ID: 22056378
[No Abstract] [Full Text] [Related]
16. Invasive aspergillosis in developing countries.
Chakrabarti A; Chatterjee SS; Das A; Shivaprakash MR
Med Mycol; 2011 Apr; 49 Suppl 1():S35-47. PubMed ID: 20718613
[TBL] [Abstract][Full Text] [Related]
17. 2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan.
Kung HC; Huang PY; Chen WT; Ko BS; Chen YC; Chang SC; Chuang YC; ; ; ;
J Microbiol Immunol Infect; 2018 Feb; 51(1):1-17. PubMed ID: 28781150
[TBL] [Abstract][Full Text] [Related]
18. Elderly versus nonelderly patients with invasive aspergillosis in the ICU: a comparison and risk factor analysis for mortality from the AspICU cohort.
Matthaiou DK; Dimopoulos G; Taccone FS; Bulpa P; Van den Abeele AM; Misset B; Meersseman W; Spapen H; Cardoso T; Charles PE; Vogelaers D; Blot S;
Med Mycol; 2018 Aug; 56(6):668-678. PubMed ID: 29228380
[TBL] [Abstract][Full Text] [Related]
19. Defining standards of CARE for invasive fungal diseases in solid organ transplant patients.
Garcia-Vidal C; Carratalà J; Lortholary O
J Antimicrob Chemother; 2019 Mar; 74(Suppl 2):ii16-ii20. PubMed ID: 31222312
[TBL] [Abstract][Full Text] [Related]
20. Aspergillosis: Epidemiology, Diagnosis, and Treatment.
Cadena J; Thompson GR; Patterson TF
Infect Dis Clin North Am; 2021 Jun; 35(2):415-434. PubMed ID: 34016284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
